ID28213A - Metode dan komposisi transdermal untuk meredakan rasa sakit - Google Patents

Metode dan komposisi transdermal untuk meredakan rasa sakit

Info

Publication number
ID28213A
ID28213A IDW20010231A ID20010231A ID28213A ID 28213 A ID28213 A ID 28213A ID W20010231 A IDW20010231 A ID W20010231A ID 20010231 A ID20010231 A ID 20010231A ID 28213 A ID28213 A ID 28213A
Authority
ID
Indonesia
Prior art keywords
composition
reduce pain
transdermal method
transdermal
pain
Prior art date
Application number
IDW20010231A
Other languages
English (en)
Inventor
Robert W Murdock
C Donald Williams
Original Assignee
Pharmaceuticals Applic Associa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/106,684 external-priority patent/US6290986B1/en
Application filed by Pharmaceuticals Applic Associa filed Critical Pharmaceuticals Applic Associa
Publication of ID28213A publication Critical patent/ID28213A/id

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
    • A61K31/5513—1,4-Benzodiazepines, e.g. diazepam or clozapine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Rheumatology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IDW20010231A 1998-06-29 1999-06-29 Metode dan komposisi transdermal untuk meredakan rasa sakit ID28213A (id)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/106,684 US6290986B1 (en) 1996-10-24 1998-06-29 Method and composition for transdermal administration of pharmacologic agents
US12290399P 1999-03-05 1999-03-05

Publications (1)

Publication Number Publication Date
ID28213A true ID28213A (id) 2001-05-10

Family

ID=26803907

Family Applications (1)

Application Number Title Priority Date Filing Date
IDW20010231A ID28213A (id) 1998-06-29 1999-06-29 Metode dan komposisi transdermal untuk meredakan rasa sakit

Country Status (18)

Country Link
EP (1) EP1093348A4 (id)
JP (1) JP2002519310A (id)
KR (1) KR20010078754A (id)
CN (1) CN1331576A (id)
AU (1) AU4841599A (id)
BG (1) BG105175A (id)
BR (1) BR9912508A (id)
CA (1) CA2335837A1 (id)
HR (1) HRP20000905A2 (id)
HU (1) HUP0102728A3 (id)
ID (1) ID28213A (id)
IL (1) IL140420A0 (id)
MX (1) MXPA00012767A (id)
NO (1) NO20006604L (id)
PL (1) PL345216A1 (id)
SK (1) SK20012000A3 (id)
TR (1) TR200003801T2 (id)
WO (1) WO2000000120A1 (id)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6572880B2 (en) * 1996-10-24 2003-06-03 Pharmaceutical Applications Associates Llc Methods and transdermal compositions for pain relief
NZ500590A (en) 1997-04-22 2001-11-30 Cocensys Inc Carbocyclic and heterocyclic substituted semicarbazones and thiosemicarbazones and the use thereof
EP1459750B1 (en) * 1999-07-01 2005-06-01 Pharmacia & Upjohn Company LLC (S,S)-reboxetine for treating fibromyalgia and other somatoform disorders
DE60035232T2 (de) 1999-07-01 2008-02-14 Pharmacia & Upjohn Co. Llc, Kalamazoo (S,S)-Reboxetin zur Behandlung von chronischem Müdigkeits-Syndrom
AU1261501A (en) * 1999-12-06 2001-06-18 Stanley L. Gore Compositions and methods for intranasal delivery of active agents to the brain
IN191512B (id) * 2000-01-21 2003-12-06 Panacea Biotech
DE10032132A1 (de) * 2000-07-01 2002-01-17 Lohmann Therapie Syst Lts Dermales Therapeutisches System enthaltend nichtsteroidale Antiphlogistika mit selektiver COX-2-Hemmung
WO2002007721A2 (en) * 2000-07-20 2002-01-31 Lauras As Use of cox-2 inhibitors for preventing immunodeficiency
DE10042412B4 (de) * 2000-08-30 2005-12-22 Lts Lohmann Therapie-Systeme Ag Transdermales therapeutisches System zur Abgabe von Venlafaxin, und seine Verwendung
US20040001889A1 (en) 2002-06-25 2004-01-01 Guohua Chen Short duration depot formulations
SI1575569T1 (sl) 2002-12-13 2010-12-31 Durect Corp Oralni sistem dostave zdravila, ki obsega visokoviskozne tekoče nosilne materiale
JP2005154368A (ja) * 2003-11-27 2005-06-16 Teikoku Seiyaku Co Ltd ジソピラミド含有神経因性疼痛の鎮痛剤
JP4807721B2 (ja) * 2004-01-29 2011-11-02 株式会社 メドレックス 消炎鎮痛外用剤
EP3103477A1 (en) 2004-09-17 2016-12-14 Durect Corporation Sustained local anesthetic composition containing saib
US20070027105A1 (en) 2005-07-26 2007-02-01 Alza Corporation Peroxide removal from drug delivery vehicle
JP2007308403A (ja) * 2006-05-17 2007-11-29 Kenji Yoshida 皮膚外用剤
KR100880748B1 (ko) * 2006-08-29 2009-02-02 정헌택 디메톡시커큐민을 함유하는 혈관재협착 방지용 조성물
PL2117521T3 (pl) 2006-11-03 2012-11-30 Durect Corp Transdermalne systemy dostarczania zawierające bupiwakainę
US9511016B2 (en) * 2007-06-12 2016-12-06 Epicentrx, Inc. Topical composition for treating pain
EP3326621A1 (en) 2007-12-06 2018-05-30 Durect Corporation Oral pharmaceutical dosage forms
US20100260844A1 (en) 2008-11-03 2010-10-14 Scicinski Jan J Oral pharmaceutical dosage forms
EP2428211A4 (en) * 2009-05-07 2013-04-03 Moon & J Inc PHARMACEUTICAL COMPOSITION FOR THE PREVENTION OR TREATMENT OF NEURAL DAMAGE AND NEUROLOGICAL DISEASES
US8491927B2 (en) * 2009-12-02 2013-07-23 Nimble Epitech, Llc Pharmaceutical composition containing a hypomethylating agent and a histone deacetylase inhibitor
US9572885B2 (en) 2013-03-15 2017-02-21 Durect Corporation Compositions with a rheological modifier to reduce dissolution variability
EP3104840B8 (en) * 2014-02-11 2019-07-10 Latitude Pharmaceuticals Inc. Parenteral compositions of celecoxib
SG11201811760VA (en) 2016-07-06 2019-01-30 Durect Corp Oral dosage form with drug composition, barrier layer and drug layer
AU2019365255B2 (en) 2018-10-26 2025-06-12 Viramal Limited Mucoadhesive gel composition
ES2948955T3 (es) 2018-11-30 2023-09-22 Viramal Ltd Un método de preparación de un agente gelificante, el agente gelificante obtenido de este modo y el uso de dicho agente gelificante
EP4090353A4 (en) 2020-01-13 2023-08-09 Durect Corporation DELAYED-RELEASE DRUG DELIVERY SYSTEMS WITH REDUCED IMPURITIES AND RELATED PROCEDURES
FR3108841B1 (fr) * 2020-04-06 2023-11-03 Algotherapeutix Composition pharmaceutique topique sous forme de gel aqueux comprenant au moins de l’amitriptyline
JP2024503402A (ja) 2021-01-12 2024-01-25 デュレクト コーポレーション 徐放性薬物送達システム及び関連の方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4395420A (en) * 1981-12-09 1983-07-26 Bernstein Joel E Method and composition for treating pruritis
SI9300468A (en) * 1992-10-14 1994-06-30 Hoffmann La Roche Injectable composition for the sustained release of biologically active compounds
GB9315856D0 (en) * 1993-07-30 1993-09-15 Wellcome Found Stabilized pharmaceutical
US5654337A (en) * 1995-03-24 1997-08-05 II William Scott Snyder Topical formulation for local delivery of a pharmaceutically active agent
US5837289A (en) * 1996-07-23 1998-11-17 Grasela; John C. Transdermal delivery of medications using a combination of penetration enhancers
US5885597A (en) * 1997-10-01 1999-03-23 Medical Research Industries,Inc. Topical composition for the relief of pain

Also Published As

Publication number Publication date
KR20010078754A (ko) 2001-08-21
HUP0102728A2 (hu) 2002-03-28
PL345216A1 (en) 2001-12-03
NO20006604L (no) 2001-02-28
BG105175A (bg) 2001-11-30
MXPA00012767A (es) 2002-08-09
AU4841599A (en) 2000-01-17
TR200003801T2 (tr) 2001-06-21
SK20012000A3 (sk) 2001-08-06
WO2000000120A9 (en) 2000-03-30
NO20006604D0 (no) 2000-12-22
CN1331576A (zh) 2002-01-16
HRP20000905A2 (en) 2001-08-31
IL140420A0 (en) 2002-02-10
CA2335837A1 (en) 2000-01-06
JP2002519310A (ja) 2002-07-02
HUP0102728A3 (en) 2002-12-28
BR9912508A (pt) 2001-05-02
EP1093348A4 (en) 2003-07-16
WO2000000120A1 (en) 2000-01-06
EP1093348A1 (en) 2001-04-25

Similar Documents

Publication Publication Date Title
ID28213A (id) Metode dan komposisi transdermal untuk meredakan rasa sakit
ID29298A (id) Metode dan komposisi untuk mengobati apnea selama tidur
ID28728A (id) Komposisi dan proses pengkrepan
ID26964A (id) Komposisi dan metode untuk pengaturan pengaktifan limfosit
ID26104A (id) Metoda-metoda dan bahan-bahan untuk mengobati dan mencegah radang jaringan mukosa
ID17007A (id) Film susunan penghalang dan metode untuk menghasilkannya
HUP0102262A3 (en) Improvements in or relating to building elements and methods in relation to same
FI981751A0 (fi) Alhaisen kitkan laiva ja menetelmä pintakitkan vähentämiseksi
ID25427A (id) Proses-proses dan zat-zat antara untuk membuat senyawa-senyawa anti-kanker
EE03966B1 (et) Valuvaigistava toimega ühendid ja nende valmistamise meetod
ID30037A (id) Metoda untuk mereduksi tingkat serum trigliserida dan untuk menghambat angiogenesis menggunakan asam-asam indolalkanoat tersubstitusi
ID26161A (id) Serat poliester dan metode untuk membuatnya
ID17437A (id) Metoda dan komposisi untuk membuat kulit terang
DE69721286D1 (de) Befestigungsvorrichtung sowie anwendungsverfahren dafür
DE69700884D1 (de) In flüssiger Form zu applizierende, wasserabweisende Zusammensetzung
FI971349L (fi) Asfaltin irrote ja käyttömenetelmä
FI950051L (fi) Endoglukanaasien ja sellobiohydrolaasien yhdistetty vaikutus
FI970369A0 (fi) Menetelmä interferenssin vähentämiseksi ja radiojärjestelmä
FI981506A0 (fi) Elastomeerikompositio ja sen valmistusmenetelmä
GB9814619D0 (en) Materials and methods relating to encapsulation
ID30135A (id) Komposisi-komposisi dan metode-metode untuk mengontrol serangga-serangga
DE69919549D1 (de) Sauerstoffabsorbierende zusammensetzung und ihre anwendungsmethode
ID30044A (id) Metode dan komposisi untuk meminimkan pengotor biologi dan koloid
ID28025A (id) Metode pembuatan aminonitril dan diamina
ID26704A (id) Pemercepat bmp-4 manusia dan metode untuk menyelidiki substansi yang berhubungan dengan tulang dengan menggunakan hal yang sama